These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 19470506)

  • 1. Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.
    Feuerriegel S; Cox HS; Zarkua N; Karimovich HA; Braker K; Rüsch-Gerdes S; Niemann S
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3353-6. PubMed ID: 19470506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
    J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene.
    Jugheli L; Bzekalava N; de Rijk P; Fissette K; Portaels F; Rigouts L
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5064-8. PubMed ID: 19752274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
    Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
    BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of
    Bablishvili N; Tukvadze N; Shashkina E; Mathema B; Gandhi NR; Blumberg HM; Kempker RR
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.
    Sowajassatakul A; Prammananan T; Chaiprasert A; Phunpruch S
    BMC Microbiol; 2014 Jun; 14():165. PubMed ID: 24953243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
    Jnawali HN; Hwang SC; Park YK; Kim H; Lee YS; Chung GT; Choe KH; Ryoo S
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):187-96. PubMed ID: 23561273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
    Kambli P; Ajbani K; Nikam C; Sadani M; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
    Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.
    Brossier F; Veziris N; Aubry A; Jarlier V; Sougakoff W
    J Clin Microbiol; 2010 May; 48(5):1683-9. PubMed ID: 20335420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of mutations associated with resistance to second line drugs in Mycobacterium tuberculosis patients from Casablanca, Morocco.
    Momen G; Aainouss A; Lamaammal A; Chettioui F; Blaghen M; Messoudi M; Belghmi K; Mouslim J; El Mzibri M; El Messaoudi MD; Khyatti M; Chaoui I
    Rev Inst Med Trop Sao Paulo; 2021; 63():e19. PubMed ID: 33787739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France.
    Brossier F; Pham A; Bernard C; Aubry A; Jarlier V; Veziris N; Sougakoff W;
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.
    Dymova MA; Cherednichenko AG; Alkhovik OI; Khrapov EA; Petrenko TI; Filipenko ML
    BMC Infect Dis; 2014 Sep; 14():478. PubMed ID: 25186134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
    Khanna A; Raj VS; Tarai B; Sood R; Pareek PK; Upadhyay DJ; Sharma P; Rattan A; Saini KS; Singh H
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4789-93. PubMed ID: 20713679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review.
    Georghiou SB; Magana M; Garfein RS; Catanzaro DG; Catanzaro A; Rodwell TC
    PLoS One; 2012; 7(3):e33275. PubMed ID: 22479378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.
    Engström A; Perskvist N; Werngren J; Hoffner SE; Juréen P
    J Antimicrob Chemother; 2011 Jun; 66(6):1247-54. PubMed ID: 21427106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China.
    Zhang Z; Liu M; Wang Y; Pang Y; Kam KM; Zhao Y
    Eur J Clin Microbiol Infect Dis; 2014 Nov; 33(11):1959-66. PubMed ID: 24906439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Characterization of Resistance to Second-Line Anti-Mycobacterial Drugs among Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis.
    Habibnia S; Karami-Zarandi M; Zaker S; Ghalavand Z; Doustdar F; Eslami G; Kazemian H
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China.
    Hu Y; Hoffner S; Wu L; Zhao Q; Jiang W; Xu B
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3857-63. PubMed ID: 23733477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China.
    Chen J; Chen Z; Li Y; Xia W; Chen X; Chen T; Zhou L; Xu B; Xu S
    Braz J Infect Dis; 2012; 16(2):136-41. PubMed ID: 22552454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide capreomycin antibiotics in Korea.
    Jnawali HN; Yoo H; Ryoo S; Lee KJ; Kim BJ; Koh WJ; Kim CK; Kim HJ; Park YK
    World J Microbiol Biotechnol; 2013 Jun; 29(6):975-82. PubMed ID: 23329063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.